| Term 
 | Definition 
 
        | Imatinib/Gleevec (Inhibiteurs de tyrosine-kinase) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nilotinib/Tasigna (Inhibiteurs de tyrosine-kinase) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gefitinib/Iressa (Inhibiteurs de tyrosine-kinase) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Erlotinib/Tarceva (inhibiteurs de tyrosine-kinase) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lapatinib/Tykerb (Inhibiteurs de tyrosine-kinase) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sorafenib/Nexavar (Inhibiteurs de kinase) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vémurafénib/Zelboraf (Inhibiteurs de kinase) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Temsirolimus/Torisel (Inhibition de mTOR) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Evérolimus/Afinitor (Inhibition de mTOR) |  | 
        |  |